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(Received in revised form 5 August 1986) Abstract-Little is known about how generosity of insurance and population characteristics affect quantity or appropriateness of antibiotic use. Using insurance claims for antibiotics from 5765 non-elderly people who lived in six sites in the United States and were randomly assigned to insurance plans varying by level of cost-sharing, we describe how antibiotic use varies by insurance plan, diagnosis and health status, geographic area, and demographic characteristics. People with free medical care used 85% more antibiotics than those required to pay some portion of their medical bills (controlling for all other variables). Antibiotic use was significantly more common among women, the very young, patients with poorer health, and persons with higher income. Use of antibiotics for viral, viral-bacterial, and bacterial conditions did not differ between free and cost-sharing insurance plans, given antibiotics were the treatment of choice. Cost sharing reduced inappropriate and appropriate antibiotic use to a similar degree.
INTRODUCTION
THE VOLUME of antibiotics used in this country is enormous, 105 million prescriptions in 1980 [l] , but surprisingly little is known about their use in the general population.
Even descriptive data relating antibiotic use to demographics tends to be limited to those gleaned from special groups such as Medicaid recipients [2, 3] . [24] . Such programs do not, however, ease problems of restricted access to necessary antibiotic therapy owing to financial barriers such as inade-' quate insurance coverage. Providing free medical care to all persons increases access to care. This could improve the quality of antibiotic use, but it could just as likely increase both inappropriate antibiotic use and harmful side effects.
To understand how antibiotics are used, we analyzed data from insurance claims collected as part of the Rand Health Insurance Experiment. We describe how the use of antibiotics in a general non-elderly population varies by gen-erosity of insurance, patient demographics, geographic area of the United States, health status, and diagnosis, About 3% of the families contacted were excluded from the experiment because their annual income exceeded $58,000 (in 1984 dollars). Also excluded were families in which the head of household was eligible for Medicare or who would become so before the end of the study. Additionally, families participating in the Supplemental Security Income (SSI) program, those eligible for the military medical system, and institutionalized individuals (e.g. in prison or in mental institutions) were excluded.
METHODS

The Rand Health Insurance Experiment
Except for these intentional differences, families were representative of the general population of the area where they resided [9] .
Families electing to enroll in the experiment were assigned to one of 14 fee-for-service insurance plans by a random-sampling method that made the distribution of family characteristics as similar as possible in each plan [lo] . For the analyses presented here, each plan was assigned to one of two categories.
First, in the freecare plan, families received all medical services free of charge (0% coinsurance).
The second category comprised all the cost-sharing plans, in which families paid 25, 50, or 95% of their medical bills out-of-pocket up to a stipulated maximum each year that was tied directly to family income. aminoglycosides; and nitrofurans. The quantity of pills prescribed per prescription and dosage levels used did not vary by plan, so we did not adjust for these factors in our analyses.
Assigning diagnoses to antibiotics
We linked each antibiotic to a specific diagnosis. Most often, the prescribing physician made the diagnosis link and recorded it on the insurance form. In a few cases multiple diagnoses were recorded and not linked to drug therapy. After reviewing a complete patient profile, a physician at Rand (GAG), who was blinded to the insurance coverage of the patient, assigned the diagnosis that probably triggered the antibiotic therapy. When an antibiotic could be linked to two diagnoses (2% of the total), the first diagnosis listed by the physician was counted. A diagnosis could be determined for 3793 of 3903 antibiotic claims (97%). After linking each antibiotic to a diagnosis, we coded diagnoses into 150 homogeneous groups (an expanded version of an earlier listing of 92 "diagnosis clusters" [l 11). Finally, we specified four diagnostic categories for which antibiotics might be appropriately or inappropriately prescribed (Table l) , according to whether an illness was likely to be bacterial (e.g. streptococcal sore throat) or viral (e.g. influenza) or to be one for which antibiotics are standard therapy (e.g. acne).
Estimating use of antibiotics by patient characteristics and insurance plan
We examined differences between groups (such as adults and children or persons who contusions, and other injuries IV. All other conditions1 *Hay fever is included here because using antibiotics to treat hay fever is analogous to using antibiotics to treat viral conditions. tNot all of these conditions are bacterial in the strict medical sense, but they are included in this category because antibiotic or other antimicrobial usage is accepted, standard therapy when an infection is considered present. $A11 other diagnoses and problems for which care was obtained in the second year of the experiment.
Types of Antibiotics used by Children and Adults
Among children (< 14 yr of age) the most commonly used oral antibiotics were amoxicillin/ampicillin (35%), penicillins (30%), and erythromycin (17%) ( Table 2 ). Two percent of the antibiotics prescribed for children were tetracyclines (about three-quarters of which were for children 9 or older). Among adults, tetracyclines (25%) were the most commonly used antibiotic, followed by relatively equal use of penicillins, amoxicillin/ampicillin, and erythromycin.
were in good or poor health) with multi-level contingency tables and simple descriptive statistics. We then determined the rate of antibiotic use for each level of the variable of interest and calculated ratios of those rates (e.g. the ratio of the rate of antibiotic use among women to that among men). A Taylor's series 95% confidence interval was calculated for each ratio [12] . If the confidence interval does not include 1.0, the difference between the two groups is statistically significant at the 0.05 level (two-tailed test).
Injectable antibiotics accounted for 10% of total antibiotic use. The most commonly injected agents were the penicillins (children, 82% of all injectable antibiotics; adults, 48%). Among children, the second-ranking injectable antibiotics were amoxicillin/ampicillin (8%) followed by lincomycin or clindamycin (4%). Among adults, the next two commonly injected antibiotics were lincomycin or clindamycin (28%) and tetracyclines (17%).
Relationship of Antibiotic Use to Demographic and Plan Variables Age and sex
To explain antibiotic use while controlling for Taking all insurance plans together, children the effects of several variables simultaneously, 6 yr and younger used oral antibiotics most we used multiple regression techniques. The frequently: more than 1 antibiotic per child per number of prescriptions purchased during the year (Table 3) 1.53) as likely to use an oral antibiotic as were men.
Injected antibiotics per person per year averaged 0.07. Injections were most common among children 6 and younger (0.09) and among adults 40 and older (0.12). As with oral antibiotics, injections were more common among women than men (0.08 and 0.06 per person per year; female:male ratio, 1.31; CI: 1.08, 1 S8).
Health status
Even though most antibiotics are used for acute conditions, we expected them to be used mainly by individuals in poorer health. To test this hypothesis, we calculated rates of use for persons who were considered to be in "ill health" at the beginning of the second study year according to values on a self-or parentassessed general health ratings index.
All persons whose score on this index was below the median for their age and sex group used more antibiotics annually than those with better-than-average health status. Oral antibiotics were 1.47 times as likely to be used (CI: Family income and plan. Regardless of plan, people in the lowest third of the income distribution (adjusted for geographic area) used the fewest antibiotics (Table 4) . Having free care significantly diminished the effect of income on use of antibiotics.
With free care, persons in the highest income group used about one-third more antibiotics than did those in the lowest income group; on the cost-sharing plans, use among persons with the highest incomes was about three-quarters again as great. For oral antibiotics the largest free-to-costsharing ratio occurred among persons in the lowest income group (Table 4) ; their ratio of 2.17 was significantly different from those of persons in the middle or upper thirds of the income distribution.
People in the lowest income tertile had the fewest injections regardless of insurance plan; poor people on the free plan used 60% more injected antibiotics than those on the cost-sharing plans.
Eflects of insurance plan, income, age, sex, site, ill health on use of oral antibiotics
Antibiotic use was associated with several demographic and experimental variables when examined one at a time. To understand the collective and separate effects of these variables, we used a negative binomial regression model to estimate the rate of oral antibiotic use [16] . Cost sharing, older age, being male, having lower income, and being in better health were all significantly associated with using fewer oral antibiotics per person per year. The ratios produced by the model are very close to those found in the univariate and bivariate analyses. For example, even when no other variables are controlled for, individuals on the free plan used 80% more antibiotics than those on the costsharing plans; when age, sex, income, health status, and geographic area are held constant, we estimate 85% more antibiotic use on the free plan. These similarities are not surprising because demographic characteristics were balanced across plans at the beginning of the experiment. Table 5 presents several examples of annual rates of oral antibiotic use predicted by our multivariate model, holding geographic site and health status constant.
For example, we estimate that high-income girls on the free plan used 2.48 antibiotics per year (the highest rate among the various groups examined); at 0.09 per year, low-income men on the cost-sharing plan used the fewest antibiotics.
We can use these examples to address more concretely two important questions: "Given that a person is poor, how much more will that Being female, being young, being in "ill health" (below the median of a parent-or self-assessed health ratings index), and being of higher income led to significantly higher rates of antibiotic use. Other work in the Health Insurance
Experiment has shown that annual drug expenditures in an ambulatory setting rise as the level of cost sharing falls [19] . Drug expenditures per person on the free care plan were about 60% higher than on our least generous plans (95% coinsurance).
This increase in total drug expenditures is about the same as that observed for total per capita outpatient expenditures and suggests that drug use increased at the same rate as did physician visits. The number of total prescriptions purchased per person was significantly higher on the free plan and varied across plans in the same fashion as did drug expenditures.
Finally, no difference was found by plan for average charge per prescription so plan differences are related to the quantity of drugs purchased. Thus, the effect of cost sharing on antibiotic use comes principally through a reduction in visits rather than as a result of reduced antibiotic prescribing given a visit. The types of antibiotics purchased were similar for participants on the free and cost-sharing plans. Moreover, the pattern was consistent with that reported by the National Ambulatory Medical Care Survey [1], so our experimental population's aggregate use of antibiotics reflects what might be expected for the nation as a whole.
Antibiotic use varied widely, however, across our four regions: highest in the Central region site, lowest in the Northeast sites. These variations were not explained by income or other population differences. The symptoms or conditions for which our participants sought care (apart from the higher use associated with free tTaylor's series 95% confidence intervals [13] ; ratio and confidence intervals calculated using 8 significant digits.
care per se) and variations in the type of physician and his or her training may explain part or all of the site differences in antibiotic use; this question is currently under investigation.
Was free care likely to increase antibiotic use nonspecificially or only for appropriate diagnoses? At the beginning of the experiment, families were randomly assigned to insurance plans, and we observed no differences by plan in the prevalence of over two dozen chronic conditions such as acne or several acute illnesses such as otitis media [20, 21] . Hence, we would not expect the incidence of ailments for which antibiotic treatment would be the norm to differ by plan. We observed, however, that antibiotic use was greater on the free than on the cost-sharing plans across all diagnoses, even those where antibiotic use is not beneficial (i.e. viral conditions). Thus, free care evidently had a general, nonspecific effect on increasing antibiotic use. Although antibiotics have unquestionable benefits, they also have adverse effects. We estimate using published rates [22] of adverse reactions associated with each antibiotic class that 5 serious adverse effects from antibiotics would have occurred per 1000 persons enrolled on the cost-sharing plans as compared with 10 per 1000 on the free plan. For mild plus serious adverse effects the figures are 44 and 65 per 1000 on the cost-sharing and free plans, respectively. Based on the physician's reason for using an antibiotic, 18% of the possible serious adverse drug reactions (across all plans) would be associated with antibiotics given for viral conditions.
Thus, cost-sharing reduced an individual's probability of suffering an adverse effect because the overall rate of antibiotic use was lower on cost-sharing plans. It did not, however, decrease the probability that an adverse reaction (if experienced) was caused by inappropriate use of the drug. As a possible strategy for dealing with inappropriate antibiotic use, cost sharing falls short on two counts. On average, cost sharing lowered antibiotic use by 46%; although a considerable amount of inappropriate prescribing remained, the rate of appropriate use was also reduced to a similar degree. is not a bad approximation, Second, the mean and variance of the distribution of prescriptions should be equal to A for the Poisson to be a good approximation.
This assumption is too restrictive. Instead of assuming all A, are equal to a common constant, we assume they are distributed according to a gamma distribution, turning our model back into a negative binomial model. The negative binomial model works in the following way. A gamma distribution can represent a wide range of functions, depending on the value of 8, which is to be estimated. We can interpret A, as follows: For every person, we have a set of observable characteristics, x,, which affect antibiotic use. In addition for every person, there are characteristics we did not observe, and these factors also influence use. Therefore, we may have two persons with identical values of independent variables but with different levels of antibiotic use. Different realizations, A, and A,, from the gamma distributions, r(0), may be assumed to be the reason for this unexplained difference in use levels of these observations. In drawing inferences, we cannot make different predictions for these two observations, but our inferences will indicate the general tendency of the use rate, given a set of values for the independent variables. Individuals will have different realizations of use rates around this general tendency according to a gamma distribution.
In sum, this model incorporates our ignorance about decisions to use antibiotics by individuals but allows us to make inferences about the general tendency to use antibiotics. Table Al gives pertinent information about the final model used to generate the predictions shown in Table 5 of the main text.
